Literature DB >> 2502894

Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.

T Meloni1, G Forteleoni, A Ogana, V Franca.   

Abstract

In a 4-year 7-month-old boy with glucose-6-phosphate dehydrogenase deficiency and systemic arthritis a severe haemolytic anaemia occurred after the administration of acetylsalicylic acid. Erythrocyte fragmentation, with haemoglobin condensation zones next to clear zones, was observed on peripheral blood smears. Since viral or bacterial infections were excluded on the basis of the laboratory data, the anaemia was ascribed to aspirin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502894     DOI: 10.1159/000205562

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  5 in total

1.  PharmGKB summary: very important pharmacogene information for G6PD.

Authors:  Ellen M McDonagh; Caroline F Thorn; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-03       Impact factor: 2.089

Review 2.  Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?

Authors:  Jianle Li; Yicong Chen; Zilin Ou; Fubing Ouyang; Jiahui Liang; Zimu Jiang; Chunyong Chen; Pingping Li; Jiaxin Chen; Jiating Wei; Jinsheng Zeng
Journal:  Am J Cardiovasc Drugs       Date:  2020-12-14       Impact factor: 3.571

Review 3.  G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs.

Authors:  Germana Bancone; Cindy S Chu
Journal:  Front Pharmacol       Date:  2021-03-15       Impact factor: 5.810

Review 4.  G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.

Authors:  Lucio Luzzatto; Elisa Seneca
Journal:  Br J Haematol       Date:  2013-12-28       Impact factor: 6.998

5.  Association between aspirin-induced hemoglobin decline and outcome after acute ischemic stroke in G6PD-deficient patients.

Authors:  Yicong Chen; Jianle Li; Zilin Ou; Yusheng Zhang; Zhijian Liang; Weisheng Deng; Weixian Huang; Fubing Ouyang; Jian Yu; Shihui Xing; Jinsheng Zeng
Journal:  CNS Neurosci Ther       Date:  2021-08-08       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.